An interactive voice application’s assessment of patient well-being through analysis of their speech was highly comparable with physicians’ tracking of patient well-being, according to a study published online in PLOS One.
Resting-state electroencephalographic (EEG) data may help in predicting the outcome of escitalopram treatment in patients with major depressive disorder (MDD), suggests a study published online in JAMA Network Open.
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).
SAN DIEGO—Mental health clinicians aren't talking to their patients enough about sexual dysfunction commonly associated with depression and its treatment, Anita Clayton. MD, stated at Psych Congress 2019.
SAN DIEGO—Added to standard-of-care treatment, esketamine nasal spray rapidly reduced depressive symptoms in patients at imminent risk of suicide, according to two phase 3 trials presented at Psych Congress 2019.
Exercise is effective for both preventing and treating depression, yet the intervention does not receive the acknowledgement it warrants in clinical practice, reports a new review and meta-analysis published in Current Sports Medicine Reports.